575 related articles for article (PubMed ID: 22488701)
1. Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors.
Schmitz KH; Prosnitz RG; Schwartz AL; Carver JR
Cancer; 2012 Apr; 118(8 Suppl):2270-6. PubMed ID: 22488701
[TBL] [Abstract][Full Text] [Related]
2. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
Bustová I
Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
[TBL] [Abstract][Full Text] [Related]
3. A prospective surveillance model for rehabilitation for women with breast cancer.
Stout NL; Binkley JM; Schmitz KH; Andrews K; Hayes SC; Campbell KL; McNeely ML; Soballe PW; Berger AM; Cheville AL; Fabian C; Gerber LH; Harris SR; Johansson K; Pusic AL; Prosnitz RG; Smith RA
Cancer; 2012 Apr; 118(8 Suppl):2191-200. PubMed ID: 22488693
[TBL] [Abstract][Full Text] [Related]
4. Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer.
Binkley JM; Harris SR; Levangie PK; Pearl M; Guglielmino J; Kraus V; Rowden D
Cancer; 2012 Apr; 118(8 Suppl):2207-16. PubMed ID: 22488695
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-replacement therapy in younger women with breast cancer.
Theriault RL; Sellin RV
J Natl Cancer Inst Monogr; 1994; (16):149-52. PubMed ID: 7999457
[TBL] [Abstract][Full Text] [Related]
6. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.
Stubblefield MD; McNeely ML; Alfano CM; Mayer DK
Cancer; 2012 Apr; 118(8 Suppl):2250-60. PubMed ID: 22488699
[TBL] [Abstract][Full Text] [Related]
7. Personalizing cardiovascular disease prevention among breast cancer survivors.
Singla A; Kumar G; Bardia A
Curr Opin Cardiol; 2012 Sep; 27(5):515-24. PubMed ID: 22874128
[TBL] [Abstract][Full Text] [Related]
8. Cardiac toxicity in breast cancer survivors: review of potential cardiac problems.
Bird BR; Swain SM
Clin Cancer Res; 2008 Jan; 14(1):14-24. PubMed ID: 18172247
[TBL] [Abstract][Full Text] [Related]
9. Integrating a prospective surveillance model for rehabilitation into breast cancer survivorship care.
Gerber LH; Stout NL; Schmitz KH; Stricker CT
Cancer; 2012 Apr; 118(8 Suppl):2201-6. PubMed ID: 22488694
[TBL] [Abstract][Full Text] [Related]
10. Improving quality of life after breast cancer: prevention of other diseases.
Rozenberg S; Antoine C; Carly B; Pastijn A; Liebens F
Menopause Int; 2007 Jun; 13(2):71-4. PubMed ID: 17540137
[TBL] [Abstract][Full Text] [Related]
11. Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care.
Hayes SC; Johansson K; Stout NL; Prosnitz R; Armer JM; Gabram S; Schmitz KH
Cancer; 2012 Apr; 118(8 Suppl):2237-49. PubMed ID: 22488698
[TBL] [Abstract][Full Text] [Related]
12. Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management.
Steingart RM; Yadav N; Manrique C; Carver JR; Liu J
Semin Oncol; 2013 Dec; 40(6):690-708. PubMed ID: 24331191
[TBL] [Abstract][Full Text] [Related]
13. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK
J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656
[TBL] [Abstract][Full Text] [Related]
14. [Breast cancer in young women: epidemiology and treatment dilemmas].
van der Sangen MJ; Voogd AC; van de Poll-Franse LV; Tjan-Heijnen VC
Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2495-500. PubMed ID: 19055255
[TBL] [Abstract][Full Text] [Related]
15. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects.
Carver JR; Shapiro CL; Ng A; Jacobs L; Schwartz C; Virgo KS; Hagerty KL; Somerfield MR; Vaughn DJ;
J Clin Oncol; 2007 Sep; 25(25):3991-4008. PubMed ID: 17577017
[TBL] [Abstract][Full Text] [Related]
16. Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.
Ganz PA; Hussey MA; Moinpour CM; Unger JM; Hutchins LF; Dakhil SR; Giguere JK; Goodwin JW; Martino S; Albain KS
J Clin Oncol; 2008 Mar; 26(8):1223-30. PubMed ID: 18227530
[TBL] [Abstract][Full Text] [Related]
17. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
National Institutes of Health Consensus Development Panel
J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
[TBL] [Abstract][Full Text] [Related]
18. Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer.
Vassilopoulou-Sellin R; Theriault RL
J Natl Cancer Inst Monogr; 1994; (16):153-9. PubMed ID: 7999459
[TBL] [Abstract][Full Text] [Related]
19. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment.
Harris EE; Correa C; Hwang WT; Liao J; Litt HI; Ferrari VA; Solin LJ
J Clin Oncol; 2006 Sep; 24(25):4100-6. PubMed ID: 16908933
[TBL] [Abstract][Full Text] [Related]
20. Survivorship: adult cancer survivors.
Ganz PA
Prim Care; 2009 Dec; 36(4):721-41. PubMed ID: 19913184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]